Dr. Sara Hardy, MD
Claim this profileArea of expertise
Brain Tumor
Sara Hardy, MD has run 1 trial for Brain Tumor. Some of their research focus areas include:
Clinical Trials Sara Hardy, MD is currently running
More about Sara Hardy, MD
Clinical Trial Related
4 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical Trial
Treatments Sara Hardy, MD has experience with
- Early START Visit Using Checklist Over Telephone Or Zoom
Breakdown of trials Sara Hardy, MD has run
Brain Tumor
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Sara Hardy, MD specialize in?
Sara Hardy, MD focuses on Brain Tumor and other conditions. In particular, much of their work with Brain Tumor has involved Stage III patients, or patients who are Stage IV.
Is Sara Hardy, MD currently recruiting for clinical trials?
Yes, Sara Hardy, MD is currently recruiting for 1 clinical trial in the USA. If you're interested in participating, you should apply.
Are there any treatments that Sara Hardy, MD has studied deeply?
Yes, Sara Hardy, MD has studied treatments such as Early START visit using checklist over telephone or zoom.
What is the best way to schedule an appointment with Sara Hardy, MD?
Apply for one of the trials that Sara Hardy, MD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.